https://thepharmadata.com/novartis-launches-tender-offer-to-acquire1/ 2025-05-28T10:20:10+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Novartis-Launches-Tender-Offer-to-Acquire-Regulus-Therapeutics.webp https://thepharmadata.com/takeda-and-nature-open-2026-innovators-in/ 2025-05-28T10:28:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Takeda-and-Nature-Open-2026-Innovators-in-Science-Award-Applications.webp https://thepharmadata.com/biogen-and-city-therapeutics-partner-on1/ 2025-05-28T10:42:36+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Biogen-and-City-Therapeutics-Partner-on-Novel-RNAi-Therapy-Research_11zon.webp https://thepharmadata.com/askbio-publishes-full-phase-1b-results-of-ab/ 2025-05-28T10:51:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/AskBio-Publishes-Full-Phase-1b-Results-of-AB-1005-Gene-Therapy-for-Parkinsons-Disease.webp https://thepharmadata.com/pharma-boosts-rd-spending-despite-2024/ 2025-05-28T10:59:01+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Pharma-Boosts-RD-Spending-Despite-2024-Headwinds_11zon.webp https://thepharmadata.com/biontech-to-showcase-oncology-pipeline-progress1/ 2025-05-28T11:04:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/BioNTech-to-Showcase-Oncology-Pipeline-Progress-at-ASCO-2025_11zon.webp https://thepharmadata.com/beone-medicines-launches-in-switzerland-begins/ 2025-05-28T11:14:23+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/BeOne-Medicines-Launches-in-Switzerland-Begins-New-Global-Oncology-Chapter_11zon.webp https://thepharmadata.com/halozymes-eu-approves-subcutaneous-opdivo-with1/ 2025-05-29T09:51:16+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/EU-Approves-Subcutaneous-Opdivo-with-Halozymes-ENHANZE-for-Multiple-Tumors_11zon.webp https://thepharmadata.com/elanco-appoints-bob-vanhimbergen-to-cfo-role1/ 2025-05-29T10:00:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Elanco-Appoints-Bob-VanHimbergen-to-CFO-Role_11zon.webp https://thepharmadata.com/assembly78th-world-health-concludes-with/ 2025-05-29T10:08:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/78th-World-Health-Assembly-Concludes-with-Historic-Milestones_11zon.webp https://thepharmadata.com/who-unveils-new-framework-linking-climate-change/ 2025-05-29T10:13:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/WHO-Unveils-New-Framework-Linking-Climate-Change-and-Tuberculosis-Control_11zon.webp https://thepharmadata.com/global-member-states-back-world-prematurity-day1/ 2025-05-29T10:21:44+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Member-States-Back-World-Prematurity-Day-as-Global-Health-Campaign_11zon.webp https://thepharmadata.com/beyfortus-gains-edge-in-first-real-world-rsv/ 2025-05-30T09:50:11+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Beyfortus-Gains-Edge-in-First-Real-World-RSV-Immunization-Comparison_11zon.webp https://thepharmadata.com/cvs-health-sues-to-shield-arkansans-from-impact1/ 2025-05-30T09:56:20+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/CVS-Health-Sues-to-Shield-Arkansans-from-Impact-of-Act-624.webp https://thepharmadata.com/intellia-analysts-downplay-intellia-setback-1/ 2025-05-30T13:39:16+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Analysts-Downplay-Intellia-Setback-Gene-Therapy-Safety-Still-in-Focus.webp https://thepharmadata.com/astellas-evopoint-ink-exclusive-deal-for-cldn18/ 2025-05-30T13:46:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Astellas-Evopoint-Ink-Exclusive-Deal-for-CLDN18.2-Targeting-ADC-XNW27011_11zon-1.webp https://thepharmadata.com/naldemedine-china-accepts-nda-for-naldemedine1/ 2025-05-30T14:03:32+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/China-Accepts-NDA-for-Naldemedine-to-Treat-Opioid-Induced-Constipation_11zon.webp https://thepharmadata.com/teva-launches-acceleration-phase-of-growth/ 2025-05-30T14:17:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Teva-Launches-Acceleration-Phase-of-Growth-Strategy-at-2025-Innovation-Day_11zon.webp https://thepharmadata.com/abbvie-and-chicago-cubs-join-forces-in-the1/ 2025-05-31T10:12:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/AbbVie-and-Chicago-Cubs-Join-Forces-in-the-Fight-Against-Cancer_11zon.webp https://thepharmadata.com/mercks-kras-g12c-inhibitor-mk-1084-shows-antitumor-activity-in-early-trial/ 2025-05-31T10:42:04+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Mercks-KRAS-G12C-Inhibitor-MK-1084-Shows-Antitumor-Activity-in-Early-Trial_11zon.webp https://thepharmadata.com/mercks-zilovertamab-vedotin-shows-promising/ 2025-05-31T10:46:41+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Mercks-Zilovertamab-Vedotin-Shows-Promising-Results-in-Phase-2-DLBCL-Trial_11zon.webp https://thepharmadata.com/roches-fenebrutinib-sustains-disease-control1/ 2025-05-31T10:54:02+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Roches-Fenebrutinib-Sustains-Disease-Control-in-Relapsing-MS-for-Two-Years.webp https://thepharmadata.com/imfinzi-regimen-cuts-early-gastric-cancer-risk1/ 2025-06-02T10:19:14+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Imfinzi-Regimen-Cuts-Early-Gastric-Cancer-Risk-by-29-in-Phase-III-Trial_11zon.webp https://thepharmadata.com/camizestrant-cuts-risk-of-progression-or-death/ 2025-06-02T10:25:31+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Camizestrant-Cuts-Risk-of-Progression-or-Death-by-56-in-ESR1-Mutant-HR-Breast-Cancer_11zon.webp https://thepharmadata.com/kisqali-cuts-recurrence-risk-in-young-breast1/ 2025-06-02T10:45:01+05:30 https://thepharmadata.com/wp-content/uploads/2025/05/Enhertu-THP-Boosts-pCR-in-High-Risk-HER2-Early-Breast-Cancer-DESTINY-Breast11.webp https://thepharmadata.com/sanofi-to-acquire-blueprint-boosting-rare1/ 2025-06-02T10:43:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Sanofi-to-Acquire-Blueprint-Boosting-Rare-Immunology-Portfolio_11zon.webp https://thepharmadata.com/rusfertide-protagonist-takeda-to-present-ful/ 2025-06-02T10:54:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Protagonist-Takeda-to-Present-Full-32-Week-Phase-3-VERIFY-Results-on-Rusfertide-at-ASCO.webp https://thepharmadata.com/fda-grants-priority-review-to-nda-for-1/ 2025-06-03T10:13:53+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/FDA-Grants-Priority-Review-to-NDA-for-TransCon-CNP_11zon-1.webp https://thepharmadata.com/traditional-medicine-in-the-spotlight-at-wha78/ 2025-06-03T10:24:19+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Traditional-Medicine-in-the-Spotlight-at-WHA78_11zon.webp https://thepharmadata.com/zepzelca-jazz-tecentriq-combo-boosts-surviv1/ 2025-06-03T10:31:56+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Zepzelca-Tecentriq-Combo-Boosts-Survival-in-First-Line-SCLC-Maintenance.webp https://thepharmadata.com/viatris-reports-positive-phase-3-lynx-2-results/ 2025-06-03T10:42:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Viatris-Reports-Positive-Phase-3-LYNX-2-Results-for-MR-142-in-Vision-Impaired-Patients_11zon.webp https://thepharmadata.com/beone-highlights-promising-breast-cancer-data-1/ 2025-06-03T10:50:23+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/BeOne-Highlights-Promising-Breast-Cancer-Data-at-ASCO-2025_11zon.webp https://thepharmadata.com/cancer-genmabs-rina-s-shows-promise-in/ 2025-06-03T10:57:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Genmabs-Rina-S-Shows-Promise-in-Advanced-Endometrial-Cancer-Trial_11zon-scaled.webp https://thepharmadata.com/biontech-bms-partner-to-develop-bispecific1/ 2025-06-03T11:03:17+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/BioNTech-BMS-Partner-to-Develop-Bispecific-Cancer-Antibody-BNT327.webp https://thepharmadata.com/rare-disease-trump-tariffs-threaten-rare1/ 2025-06-03T11:11:45+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Trump-Tariffs-Threaten-Rare-Disease-and-Gene-Therapies-Industry-Warns.webp https://thepharmadata.com/lilly-unveils-first-clinical-data-for-next-gen1/ 2025-06-03T11:18:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Lilly-Unveils-First-Clinical-Data-for-Next-Gen-FRα-ADC-in-Platinum-Resistant-Ovarian-Cancer-at-ASCO-2025.webp https://thepharmadata.com/tecentriq-lurbinectedin-boost-survival-in1/ 2025-06-03T11:25:53+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Tecentriq-Lurbinectedin-Boost-Survival-in-Extensive-Stage-SCLC_11zon.webp https://thepharmadata.com/abbvie-opens-2nd-annual-migraine-career-catalys1/ 2025-06-04T10:28:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/AbbVie-Opens-2nd-Annual-Migraine-Career-Catalyst-Award-Contest_11zon.webp https://thepharmadata.com/sarclisa-asco-data-backs-subcutaneous-on-body1/ 2025-06-04T10:52:04+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Sarclisa-Data-Backs-Subcutaneous-On-Body-Delivery11.webp https://thepharmadata.com/lymphoma-ec-approves-adcetris-for-newly-1/ 2025-06-04T10:59:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/EC-Approves-ADCETRIS-for-Newly-Diagnosed-Advanced-Hodgkin-Lymphoma_11zon.webp https://thepharmadata.com/bayers-fda-approves-third-use-for-bayers-1/ 2025-06-04T11:07:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/FDA-Approves-Third-Use-for-Bayers-Nubeqa-in-Advanced-Prostate-Cancer.webp https://thepharmadata.com/legend-biotech-reports-landmark-5-year-carvyk1/ 2025-06-04T11:20:56+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Legend-Biotech-Reports-Landmark-5-Year-CARVYKTI-Data-at-ASCO-2025_11zon.webp https://thepharmadata.com/primary-health-care-on-the-rise-worldwide1/ 2025-06-05T10:14:08+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Primary-Health-Care-on-the-Rise-Worldwide-Now-Is-the-Time-to-Stand-Together.webp https://thepharmadata.com/tropical-diseasesoda-cuts-deepen-the-neglect-of1/ 2025-06-05T10:23:26+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/ODA-Cuts-Deepen-the-Neglect-of-Tropical-Diseases_11zon.webp https://thepharmadata.com/cpr-training-turns-heroic-walgreens-manager1/ 2025-06-05T10:39:30+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/CPR-Training-Turns-Heroic-Walgreens-Manager-Revives-Daughter-in-Emergency_11zon.webp https://thepharmadata.com/vividion-and-bayer-advance-oncology-pipeline1/ 2025-06-05T10:49:56+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Vividion-and-Bayer-Advance-Oncology-Pipeline-with-WRN-Inhibitor_11zon.webp https://thepharmadata.com/sanofi-launches-2025-global-stock-plan-for/ 2025-06-06T10:02:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Sanofi-Launches-2025-Global-Stock-Plan-for-Employees_11zon.webp https://thepharmadata.com/zoetis-highlights-environmental-and-social-1/ 2025-06-06T10:12:27+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Zoetis-Highlights-Environmental-and-Social-Impact-in-2024-Update_11zon.webp https://thepharmadata.com/finerenone-and-sglt2-inhibitor-combo-shows/ 2025-06-06T10:19:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Finerenone-and-SGLT2-Inhibitor-Combo-Shows-Promise-in-CKD-with-Type-2-Diabetes_11zon.webp https://thepharmadata.com/grifols-names-anne-catherine-berner-as-new1/ 2025-06-06T11:15:46+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Grifols-Names-Anne-Catherine-Berner-as-New-Board-Chair_11zon.webp https://thepharmadata.com/who-urges-protection-for-gazas-nasser-and-1/ 2025-06-06T11:30:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/WHO-Urges-Protection-for-Gazas-Nasser-and-Al-Amal-Hospitals.webp https://thepharmadata.com/immunization-at-every-stage-of-life-a-key-to1/ 2025-06-06T11:36:32+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Immunization-at-Every-Stage-of-Life-A-Key-to-Lifelong-Health_11zon.webp https://thepharmadata.com/eu-approves-fixed-duration-calquence-regimens-1/ 2025-06-07T10:02:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/EU-Approves-Fixed-Duration-Calquence-Regimens-for-1st-Line-CLL.webp https://thepharmadata.com/sanofi-showcases-rare-disease-pipeline-innovati1/ 2025-06-07T10:17:31+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Sanofi-Showcases-Rare-Disease-Pipeline-Innovations-at-ISTH_11zon.webp https://thepharmadata.com/alyftrek-vertex-highlights-alyftrek-data-and1/ 2025-06-07T10:26:40+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Vertex-Highlights-ALYFTREK®-Data-and-Sweat-Chloride-Goals-at-European-CF-Conference.webp https://thepharmadata.com/sibeprenlimab-otsukas-sibeprenlimab-shows1/ 2025-06-07T10:41:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Otsukas-Sibeprenlimab-Shows-Significant-Proteinuria-Reduction-in-Phase-3-IgAN-Trial.webp https://thepharmadata.com/who-unveils-online-training-series-to-support1/ 2025-06-07T10:55:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/WHO-Unveils-Online-Training-Series-to-Support-Chemical-Emergency-Preparedness_11zon.webp https://thepharmadata.com/jcr-pharmaceuticals-celebrates-50-years-with1/ 2025-06-10T10:01:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Celebrates.webp https://thepharmadata.com/pharma-contract-sales-outlook-2025-20301/ 2025-06-07T11:50:17+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Pharma-Contract-Sales-Outlook-2025–2030-Multilingual-Teams-Drive-Global-Expansion.webp https://thepharmadata.com/merck-fda-approves-enflonsia-to-prevent-rsv1/ 2025-06-10T10:39:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/04/Approve.webp https://thepharmadata.com/beyfortus-sanofi-speeds-up-beyfortus-shipments-1/ 2025-06-10T10:19:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Sanofi-Speeds-Up-Beyfortus-Shipments-Ahead-of-2025-2026-RSV-Season_11zon.webp https://thepharmadata.com/mercks-china-cde-accepts-mercks-pimicotinib1/ 2025-06-10T10:40:46+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/China-CDE-Accepts-Mercks-Pimicotinib-Application-for-TGCT-Treatment_11zon.webp https://thepharmadata.com/amvuttra-alnylam-wins-eu-ok-for-amvuttra1/ 2025-06-10T10:50:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Alnylam-Wins-EU-OK-for-AMVUTTRA-to-Treat-ATTR-CM_11zon.webp https://thepharmadata.com/wuxi-biologics-visen-partner-to-make-1/ 2025-06-10T10:59:59+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/WuXi-Biologics-VISEN-Partner-to-Make-Lonapegsomatropin-in-Chengdu_11zon.webp https://thepharmadata.com/jazz-pharma-unveils-late-stage-xywav-data-in1/ 2025-06-10T11:15:20+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Jazz-Pharma-Unveils-Late-Stage-Xywav®-Data-in-Narcolepsy-at-SLEEP-2025.webp https://thepharmadata.com/emergency-fourth-ihr-meeting-on-2024-mpox1/ 2025-06-10T11:23:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Fourth-IHR-Emergency-Meeting-on-2024-Mpox-Surge-–-Temporary-Recommendations.webp https://thepharmadata.com/transcon-cnp-shows-enhanced-benefits-in-1/ 2025-06-10T11:31:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/TransCon-CNP-Shows-Enhanced-Benefits-in-Children-with-Achondroplasia-at-Week-26-of-COACH-Trial_11zon.webp https://thepharmadata.com/mavyret-fda-approves-expanded-use-of-abbvies1/ 2025-06-12T10:18:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/FDA-Approves-Expanded-Use-of-AbbVies-MAVYRET-for-Acute-Hepatitis-C_11zon.webp https://thepharmadata.com/bristol-myers-squibb-unveils-positive-phase-3/ 2025-06-12T10:32:05+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Bristol-Myers-Squibb-Unveils-Positive-Phase-3-Data-for-Sotyktu-in-Psoriatic-Arthritis_11zon.webp https://thepharmadata.com/dapirolizumab-pegol-phase-3-data-shows-sle/ 2025-06-12T10:42:47+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Dapirolizumab-Pegol-Phase-3-Data-Shows-SLE-Fatigue-and-Disease-Activity-Improvement-at-EULAR_11zon.webp https://thepharmadata.com/bayer-broad-institute-extend-cardiovascular-1/ 2025-06-12T10:46:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Bayer-Broad-Institute-Extend-Cardiovascular-Drug-Research-Pact.webp https://thepharmadata.com/argenx-unveils-positive-efgartigimod-pha1/ 2025-06-12T10:53:02+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/argenx-Unveils-Positive-Efgartigimod-Phase-2-Data-in-Myositis-and-Sjogrens-at-EULAR-2025.webp https://thepharmadata.com/beones-fda-approves-tablet-form-of-beone1/ 2025-06-13T09:42:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/02/Galdermas-Nemluvio®-Approved-in-UK-Switzerland-for-Skin-Conditions-2.webp https://thepharmadata.com/parliamentarians-gather-for-annual-world-health1/ 2025-06-12T11:23:53+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Parliamentarians-Gather-for-Annual-World-Health-Assembly_11zon.webp https://thepharmadata.com/patient-first-dosed-in-phase-3-reveal-trial-of/ 2025-06-13T09:41:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/First-Patient-Dosed-in-Phase-3-REVEAL-Trial-of-ION582-for-Angelman-Syndrome.webp https://thepharmadata.com/bleximenib-shows-promise-with-venetoclax-and1/ 2025-06-13T10:13:19+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Bleximenib-Shows-Promise-with-Venetoclax-and-Azacitidine-in-AML_11zon.webp https://thepharmadata.com/merck-animal-health-gets-eu-cvmp-positive1/ 2025-06-13T10:23:17+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Merck-Animal-Health-Gets-EU-CVMP-Positive-Opinion-for-NUMELVI-Tablets-for-Dogs.webp https://thepharmadata.com/fabhalta-novartis-boosts-hemoglobin-in-pnh1/ 2025-06-13T10:38:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Novartis-Fabhalta®-Boosts-Hemoglobin-in-PNH-Patients.webp https://thepharmadata.com/wp-content/uploads/2025/06/Hemoglobin_11zon.webp https://thepharmadata.com/rilzabrutinib-cuts-flares-in-igg4-related-1/ 2025-06-13T17:46:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Rilzabrutinib-Cuts-Flares-in-IgG4-Related-Disease_-Fast-Track-Granted-in-US.webp https://thepharmadata.com/bristol-myers-squibb-highlights-targeted1/ 2025-06-13T11:05:46+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Bristol-Myers-Squibb-Highlights-Targeted-Protein-Degradation-Data-Including-CELMoD-Agents-at-EHA-2025_11zon.webp https://thepharmadata.com/gsk-licenses-shigella-vaccine-candidate-1/ 2025-06-13T11:17:56+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/GSK-Licenses-Shigella-Vaccine-Candidate-to-Bharat-Biotech_11zon.webp https://thepharmadata.com/enpatoran-merck-sharessafety-data-at-eular-2025/ 2025-06-13T11:24:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Merck-Shares-Enpatoran-SLE-Efficacy-Safety-Data-at-EULAR-2025.webp https://thepharmadata.com/dapirolizumab-pegol-phase-3-data-shows/ 2025-06-13T11:31:16+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Dapirolizumab-Pegol-Phase-3-Data-Shows-Fatigue-Improvement-and-Disease-Activity-Reduction-at-EULAR_11zon.webp https://thepharmadata.com/jjs-dual-target-car-t-cell-therapy-shows1/ 2025-06-14T10:28:59+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/JJs-Dual-Target-CAR-T-Cell-Therapy-Shows-Promise-in-Large-B-Cell-Lymphoma.webp https://thepharmadata.com/wp-content/uploads/2025/06/JJs-Dual-Target-CAR-T-Cell-Therapy-Shows-Promise-in-Large-B-Cell-Lymphoma-1-1024x682.webp https://thepharmadata.com/treatment-fda-approves-keytruda-for-neoadjuvant1/ 2025-06-14T10:44:08+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/FDA-Approves-KEYTRUDA-for-Neoadjuvant-and-Adjuvant-Treatment-of-PD-L1-Resectable-Head-Neck-Cancer_11zon.webp https://thepharmadata.com/cholesterol-amgen-barry-sanders-spotlight1/ 2025-06-14T10:58:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Amgen-Barry-Sanders-Spotlight-Bad-Cholesterol-Risks-in-Documentary_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/06/Amgen-Barry-Sanders-Spotlight-Bad-Cholesterol-Risks-in-Documentary_11zon-1-1024x491.webp https://thepharmadata.com/astellas-mitsubishi-research-institute-team-1/ 2025-06-14T11:12:45+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Astellas-Mitsubishi-Research-Institute-Team-Up-to-Support-Japanese-Pharma-Startups_11zon.webp https://thepharmadata.com/mrna-tech-transfer-phase-2-0-discussed-at-g20/ 2025-09-30T13:00:20+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/mRNA-Tech-Transfer-Phase-2.0-Discussed-at-G20-Summit_11zon.webp https://thepharmadata.com/elancos-zenrelia-wins-positive-cvmp-opinion1/ 2025-06-14T11:41:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Elancos-Zenrelia-Wins-Positive-CVMP-Opinion.webp https://thepharmadata.com/wp-content/uploads/2025/06/Veterinary-Medicinal-Products_11zon.webp https://thepharmadata.com/extramedullary-talvey-tecvayli-provide-durabl1/ 2025-06-16T10:00:49+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/TALVEY-TECVAYLI-Provide-Durable-Responses-in-Extramedullary-Multiple-Myeloma_11zon.webp https://thepharmadata.com/roche-shares-elevidys-safety-update-in-11/ 2025-06-16T10:05:34+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Roche-shares-Elevidys-safety-update-in-non-ambulatory-Duchenne-muscular-dystrophy-patients_11zon.webp https://thepharmadata.com/asthma-eaaci-dupixent-supersedes-xolair-1/ 2025-06-16T10:19:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Sanofi_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/06/EAACI-Dupixent-Supersedes-Xolair-in-CRS-w-Nasal-Polyps-and-Asthma-Phase-4-Head-to-Head-Study_11zon-1024x761.webp https://thepharmadata.com/genmab-epcoritamab-combo-shows-high-response-1/ 2025-06-16T10:32:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Genmab-Epcoritamab-Combo-Shows-High-Response-in-Transplant-Eligible-R-R-DLBCL.webp https://thepharmadata.com/qiagen-and-incyte-partner-on-companion-dx-for1/ 2025-06-16T10:40:41+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/QIAGEN-and-Incyte-Partner-on-Companion-Dx-for-Mutant-CALR-MPNs_11zon.webp https://thepharmadata.com/sarepta-strengthens-elevidys-safe1/ 2025-06-16T10:48:41+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Sarepta-Strengthens-ELEVIDYS-Safety-Measures-for-Non-Ambulatory-Duchenne-Patients_11zon.webp https://thepharmadata.com/intellia-reports-positive-3-year-phase-1-data/ 2025-06-16T11:00:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Intellia-Reports-Positive-3-Year-Phase-1-Data-for-Lonvo-z-in-Hereditary-Angioedema_11zon.webp https://thepharmadata.com/lilly-offers-all-zepbound-doses-via-lillydirect1/ 2025-06-17T10:14:01+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Lilly-Offers-All-Zepbound-Doses-via-LillyDirect-Self-Pay-Pharmacy.webp https://thepharmadata.com/wp-content/uploads/2025/06/Lilly-Offers-All-Zepbound-Doses-via-LillyDirect-Self-Pay-Pharmacy_11zon-1024x682.webp https://thepharmadata.com/roche-advances-prasinezumab-to-phase-iii-1/ 2025-06-17T10:19:45+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Roche-Advances-Prasinezumab-to-Phase-III-for-Early-Parkinsons-Disease.webp https://thepharmadata.com/lymphoma-bms-presents-transcend-fl-data-1/ 2025-06-17T10:34:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Bristol-Myers-Squibb_11zon-1.webp https://thepharmadata.com/wp-content/uploads/2025/06/BMS-Presents-Transcend-FL-Data-Breyanzi-Shows-Durable-Responses-in-Marginal-Zone-Lymphoma_11zon-1-1024x682.webp https://thepharmadata.com/fda-approves-csls-andembry-first-once-monthly1/ 2025-06-17T10:42:05+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/FDA-Approves-CSLs-Andembry-First-Once-Monthly-Prophylactic-HAE-Treatment-Targeting-Factor-XIIa.webp https://thepharmadata.com/wuxi-apptec-extel-2025recognized-with-top-honors/ 2025-06-17T10:48:33+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Extel-2025-WuXi-AppTec-Recognized-with-Top-Honors_11zon.webp https://thepharmadata.com/biomarin-boosts-enzyme-therapy-business-with1/ 2025-06-17T11:04:10+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/BioMarin-Boosts-Enzyme-Therapy-Business-with-Inozyme-Acquisition_11zon.webp https://thepharmadata.com/wp-content/uploads/2025/06/Enzyme-Therapy-Business_11zon.webp https://thepharmadata.com/teva-and-fosun-partner-to-develop-novel1/ 2025-06-17T11:12:47+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Teva-and-Fosun-Partner-to-Develop-Novel-Anti-PD1-IL2-Immunotherapy_11zon.webp https://thepharmadata.com/abbvie-atogepant-outperforms-topiramate-in-phase-3-migraine-study/ 2025-06-19T10:44:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/AbbVie-Atogepant-Outperforms-Topiramate-in-Phase-3-Migraine-Study_11zon.webp https://thepharmadata.com/ifinatamab-phase-3-trial-of-ifinatamab-1/ 2025-06-19T10:50:49+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Phase-3-Trial-of-Ifinatamab-Deruxtecan-Begins-in-Advanced-Prostate-Cancer_11zon.webp https://thepharmadata.com/amgen-to-present-phase-2-maritide-data-at-ada/ 2025-06-19T11:10:53+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Amgen-to-Present-Phase-2-Maritide-Data-at-ADA-85th-Scientific-Sessions_11zon.webp https://thepharmadata.com/merck-names-neoclease-winner-of-2025-biotech/ 2025-06-19T11:22:26+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Merck-Names-Neoclease-Winner-of-2025-Biotech-Grant_11zon.webp https://thepharmadata.com/omaveloxolone-biogen-launches-phase-3-pedia/ 2025-06-19T11:35:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Biogen-Launches-Phase-3-Pediatric-Trial-of-Omaveloxolone-for-Friedreich-Ataxia_11zon.webp https://thepharmadata.com/alnylam-promotes-pushkal-garg-to-chief-rd-1/ 2025-06-19T14:32:04+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Alnylam-Promotes-Pushkal-Garg-to-Chief-R_D-Officer.webp https://thepharmadata.com/grifols-fibrinogen-phase-3-results-published/ 2025-06-20T10:51:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Grifols-Fibrinogen-Phase-3-Results-Published-in-eClinicalMedicine_11zon_11zon.webp https://thepharmadata.com/global-civil-society-drives-global-health-wha78/ 2025-06-20T11:00:12+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Civil-Society-Drives-Global-Health-Agenda-at-WHA78_11zon.webp https://thepharmadata.com/summit-h20-to-shape-g20-health-agenda/ 2025-06-21T09:55:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/H20-Summit-to-Shape-G20-Health-Agenda-and-Financing_11zon-e1750479898309.webp https://thepharmadata.com/lunsumio-combination-of-lunsumio-and-polivy-1/ 2025-06-21T10:21:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Combination-of-Lunsumio-and-Polivy-from-Roche-Significantly-Extends-Remission-in-RR-Large-B-Cell-Lymphoma_11zon.webp https://thepharmadata.com/fda-approves-dupixent-as-first-and-onlytargeted1/ 2025-06-21T10:31:00+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/FDA-Approves-Dupixent-as-First-and-Only-Targeted-Therapy-for-Bullous-Pemphigoid-in-the-US_11zon.webp https://thepharmadata.com/vertex-reports-favorable-zimislecel-type-1/ 2025-06-21T10:41:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Vertex-Reports-Favorable-Zimislecel-Outcomes-for-Type-1-Diabetes-at-ADA-Scientific-Sessions_11zon.webp https://thepharmadata.com/chmp-recommends-third-indication-for-bayers1/ 2025-06-21T10:54:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/CHMP-Recommends-Third-Indication-for-Bayers-Nubeqa-in-Advanced-Prostate-Cancer-Patients.webp https://thepharmadata.com/novo-nordisk-phase-3-data-shows-mim8-well/ 2025-06-23T10:47:10+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Novo-Nordisk-Phase-3-Data-Shows-Mim8-Well-Tolerated-After-Switch-from-Emicizumab-in-Hemophilia-A_11zon.webp https://thepharmadata.com/novo-nordisks-cagrisema-shows-22-7-weig/ 2025-06-23T10:56:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Novo-Nordisks-CagriSema-Shows-22.7-Weight-Loss-in-REDEFINE-1-Study-Published-in-NEJM.webp https://thepharmadata.com/roches-nxt007-shows-early-promise-for/ 2025-06-23T11:07:31+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Roches-NXT007-Shows-Early-Promise-for-Normalising-Clotting-in-Haemophilia-A_11zon.webp https://thepharmadata.com/chmp-recommends-eu-approval-of-sarclisa-for1/ 2025-06-23T11:16:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/CHMP-Recommends-EU-Approval-of-Sarclisa-for-Newly-Diagnosed-Multiple-Myeloma_11zon.webp https://thepharmadata.com/exelixis-zanzalintinib-combo-boosts-phase-3/ 2025-06-23T11:42:03+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Exelixis-Zanzalintinib-Combo-Boosts-Survival-in-Phase-3-Colorectal-Cancer-Trial_11zon.webp https://thepharmadata.com/diabetes-eu-backs-ozempic-for-pad-in-type-2/ 2025-06-24T10:51:10+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/EU-Backs-Ozempic-for-PAD-in-Type-2-Diabetes-Highlighting-Semaglutides-Broader-Benefits_11zon.webp https://thepharmadata.com/mercks-winrevair-succeeds-in-phase-3-trial-for1/ 2025-06-24T10:58:26+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Mercks-WINREVAIR-Succeeds-in-Phase-3-Trial-for-Pulmonary-Arterial-Hypertension.webp https://thepharmadata.com/datroway-wins-u-s-approval-for-previously-1/ 2025-06-24T11:11:58+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Datroway-Wins-U.S.-Approval-for-Previously-Treated-Advanced-EGFR-Mutated-NSCLC.webp https://thepharmadata.com/amgen-unveils-phase-2-obesity-trial-results-for/ 2025-06-24T11:27:36+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Amgen-Unveils-Phase-2-Obesity-Trial-Results-for-Monthly-Maritide-at-ADAs-85th-Scientific-Sessions-1-scaled.webp https://thepharmadata.com/vertex-and-ono-ink-deal-to-develop-and-1/ 2025-06-24T11:36:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Vertex-and-Ono-Ink-Deal-to-Develop-and-Commercialize-Povetacicept-in-Japan-and-South-Korea_11zon.webp https://thepharmadata.com/aetna-endorses-moves-to-simplify-prior-1/ 2025-06-24T11:43:16+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Aetna-Endorses-Moves-to-Simplify-Prior-Authorization-in-Healthcare_11zon-1.webp https://thepharmadata.com/regeneron-launches-innovative-donation-matching1/ 2025-06-25T10:07:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Regeneron-Launches-Innovative-Donation-Matching-Initiative-in-Partnership-with-Independent-Patient-Assistance-Charity_11zon.webp https://thepharmadata.com/pharma-bayer-expands-collaboration-with-tsinghua1/ 2025-06-25T10:24:48+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Bayer-Expands-Collaboration-with-Tsinghua-University-to-Boost-Pharma-RD-in-China_11zon.webp https://thepharmadata.com/baxter-releases-annual-corporate-responsibility1/ 2025-06-25T10:37:43+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Baxter-Releases-Annual-Corporate-Responsibility-Report-Highlighting-Global-Impact.webp https://thepharmadata.com/royalty-pharma-and-revolution-medicines-sign-1/ 2025-06-25T10:45:24+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Royalty-Pharma-and-Revolution-Medicines-Sign-Funding-Deals-Worth-Up-to-2-Billion_11zon.webp https://thepharmadata.com/bio-techne-joins-forces-with-usp-to-speed-up1/ 2025-06-25T10:54:08+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Bio-Techne-Joins-Forces-with-USP-to-Speed-Up-Development-of-mAbs-and-Gene-Therapies.webp https://thepharmadata.com/revolution-medicines-secures-2b-funding-from/ 2025-06-25T11:14:20+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Revolution-Medicines-Secures-2B-Funding-from-Royalty-Pharma-for-RASON-Cancer-Drug-Development_11zon-1.webp https://thepharmadata.com/lillys-amyvid-receives-fda-label-revision-to-1/ 2025-06-26T09:51:40+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Lillys-Amyvid-Receives-FDA-Label-Revision-to-Support-Alzheimers-Diagnosis.webp https://thepharmadata.com/novartis-acquires-regulus-therapeuticsexpanding1/ 2025-06-26T10:01:24+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Novartis-Acquires-Regulus-Therapeutics-Expanding-its-RNA-Based-Drug-Pipeline_11zon.webp https://thepharmadata.com/u-s-fda-grants-orphan-drug-designation-to-1/ 2025-06-26T10:12:36+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/U.S.-FDA-Grants-Orphan-Drug-Designation-to-Riliprubart-for-Treating-Antibody-Mediated-Rejection-in-Solid-Organ-Transplant-Recipients.webp https://thepharmadata.com/malaria-vaccine-price-of-worlds-firsunder-5/ 2025-06-26T10:25:54+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Price-of-Worlds-First-Malaria-Vaccine-for-Children-in-Endemic-Countries-Slashed-by-Over-50-Now-Under-5.webp https://thepharmadata.com/biogen-advances-investigational-sma-therapy-to1/ 2025-06-26T10:34:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Biogen-Advances-Investigational-SMA-Therapy-to-Registrational-Trials-After-Positive-Phase-1-Data_11zon.webp https://thepharmadata.com/beone-medicines-gains-chmp-backing-for-brukinsa1/ 2025-06-26T10:42:34+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/BeOne-Medicines-Gains-CHMP-Backing-for-BRUKINSA-Tablet-Formulation_11zon.webp https://thepharmadata.com/global-energy-access-improves-but-more-2/ 2025-06-26T10:59:09+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Global-Energy-Access-Improves-But-More-International-Financial-Support-Needed-to-Close-the-Gap.jpg https://thepharmadata.com/enflonsia-mercks-receives-acip-recommendatio1/ 2025-06-27T09:55:19+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Mercks-ENFLONSIA-Receives-ACIP-Recommendation-for-Protecting-Infants-from-Severe-RSV.webp https://thepharmadata.com/fda-approves-label-updates-for-bristol-myers-1/ 2025-06-27T10:04:55+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/FDA-Approves-Label-Updates-for-Bristol-Myers-Squibb-Cell-Therapies-Removes-REMS_11zon.webp https://thepharmadata.com/cvs-health-expands-workforce-training-with-new1/ 2025-06-27T10:09:39+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/CVS-Health-Expands-Workforce-Training-with-New-Chicago-Innovation-Center_11zon.webp https://thepharmadata.com/wuxi-apptecs-nantong-facility-honored-with-2025/ 2025-09-30T13:00:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/WuXi-AppTecs-Nantong-Facility-Honored-with-2025-Architizer-AAward-for-Seamlessly-Integrating-Technology-and-Human-Centered-Design_11zon.webp https://thepharmadata.com/beone-medicines-presents-transformativeoncology1/ 2025-06-27T10:28:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/BeOne-Medicines-Presents-Transformative-Oncology-Portfolio-at-Research-Development-Day_11zon.webp https://thepharmadata.com/incyte-names-bill-meury-as-ceo-as-hervehoppenot1/ 2025-06-27T10:39:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Incyte-Names-Bill-Meury-as-CEO-as-Herve-Hoppenot-Announces-Retirement-2-e1768283027896.webp https://thepharmadata.com/viatris-announces-success-in-second-pivotal1/ 2025-06-27T10:48:50+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Viatris-Announces-Success-in-Second-Pivotal-Phase-3-Trial-of-MR-141-Targeting-Presbyopia.webp https://thepharmadata.com/biogen-shares-promising-nusinersen-data-in1/ 2025-06-28T10:22:05+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Biogen-Shares-Promising-Nusinersen-Data-in-Continued-Mission-to-Improve-Lives-of-Those-with-SMA_11zon.webp https://thepharmadata.com/european-union-authorizes-eylea-8-mg-with-prolonged-6-month-treatment-schedule/ 2025-06-28T11:01:19+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/European-Union-Authorizes-Eylea-8-mg-with-Prolonged-6-Month-Treatment-Schedule_11zon.webp https://thepharmadata.com/ucbs-gemz-phase-3-trial-shows-promising/ 2025-06-28T11:20:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/UCBs-GEMZ-Phase-3-Trial-Shows-Promising-Results-for-Fenfluramine-in-Treating-CDKL5-Deficiency-Disorder.webp https://thepharmadata.com/who-and-key-stakeholders-launch-disability1/ 2025-06-28T12:28:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/04/CN-Bio-and-Pharmaron-Forge-Long-Term-Global-Partnership-for-OOC-Tech-Development.webp https://thepharmadata.com/who-scientific-group-publishes-findings-on1/ 2025-06-28T12:01:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/WHO-Scientific-Group-Publishes-Findings-on-COVID-19s-Origins_11zon.webp https://thepharmadata.com/naion-evaluating-the-risk-of-naion-in-patients1/ 2025-06-28T12:13:41+05:30 https://thepharmadata.com/wp-content/uploads/2025/06/Evaluating-the-Risk-of-NAION-in-Patients-Using-Semaglutide-Medications_11zon.webp https://thepharmadata.com/fda-reviews-allergans-skinvive-pma-for-neck/ 2025-07-02T10:24:09+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/FDA-Reviews-Allergans-SKINVIVE-PMA-for-Neck-Appearance-Improvement.webp https://thepharmadata.com/abbvie-to-acquire-capstan-to-boost/ 2025-07-02T10:44:24+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/AbbVie-to-Acquire-Capstan-to-Boost-Immunology-Innovation_11zon.webp https://thepharmadata.com/strategic-leadership-changes-announced-by-roche/ 2025-07-02T11:08:47+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Strategic-Leadership-Changes-Announced-by-Roche_11zon.webp https://thepharmadata.com/amgen-reports-positive-phase-3-results/ 2025-07-02T12:27:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Amgen-Reports-Positive-Phase-3-Results-for-Bemarituzumab-in-FGFR2b-Gastric-Cancer_11zon-2.webp https://thepharmadata.com/riliprubart-receives-orphan-drug-designation/ 2025-07-02T11:58:17+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Riliprubart-Receives-Orphan-Drug-Designation-in-Japan-for-CIDP_11zon.webp https://thepharmadata.com/vertexs-alyftrek-approved-in-eu-for-cystic/ 2025-07-02T12:25:25+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Vertexs-ALYFTREK®-Approved-in-EU-for-Cystic-Fibrosis-Treatment.webp https://thepharmadata.com/merck-completes-springworks-acquisition/ 2025-07-02T12:50:22+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Merck-Completes-SpringWorks-Acquisition-to-Boost-Healthcare-Growth-1.webp https://thepharmadata.com/takedas-gammagard-liquid-erc-approved/ 2025-07-02T13:12:29+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Takedas-GAMMAGARD-LIQUID-ERC-Approved-by-FDA-as-First-Ready-to-Use-Low-IgA-Immunoglobulin-Therapy.webp https://thepharmadata.com/biogen-launches-phase-3-trial-of-felzartamab/ 2025-07-02T14:25:47+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Biogen-Launches-Phase-3-Trial-of-Felzartamab-for-Primary-Membranous-Nephropathy_11zon.webp https://thepharmadata.com/argenx-advances-argx-119-for-congenital/ 2025-07-02T14:46:20+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/argenx-Advances-ARGX-119-for-Congenital-Myasthenic-Syndromes_11zon.webp https://thepharmadata.com/genmab-unveils-executive-committee-restructuring/ 2025-07-02T15:14:05+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Genmab-Unveils-Executive-Committee-Restructuring_11zon.webp https://thepharmadata.com/biomarin-completes-acquisition-of-inozyme-pharma/ 2025-07-02T15:30:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/BioMarin-Completes-Acquisition-of-Inozyme-Pharma_11zon.webp https://thepharmadata.com/wuxi-biologics-unveils-wuxihigh-2-0/ 2025-07-02T15:51:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/WuXi-Biologics-Unveils-WuXiHigh™-2.0-for-Ultra-Concentrated-Biologics.webp https://thepharmadata.com/jazz-pharma-gets-eu-nod-for-ziihera-in-advanced/ 2025-07-03T10:02:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Jazz-Pharma-Gets-EU-Nod-for-Ziihera-in-Advanced-HER2-Biliary-Cancer.webp https://thepharmadata.com/suriname-certified-malaria-free-by-wh/ 2025-07-02T16:36:11+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Suriname-Officially-Certified-Malaria-Free-by-WHO.webp https://thepharmadata.com/who-backed-testing-model-boosts-mpox-hiv/ 2025-07-02T17:03:08+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/WHO-backed-testing-model-boosts-mpox-HIV-and-syphilis-response.webp https://thepharmadata.com/lupin-unveils-new-consumer-healthcare/ 2025-07-02T17:23:57+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Lupin-Unveils-New-Consumer-Healthcare-Arm-LupinLife.webp https://thepharmadata.com/gilead-advances-in-hiv-market-with-twice-yearly-yeztugo-leaving-gsk-behind/ 2025-07-02T17:52:47+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Gilead-Advances-in-HIV-Market-With-Twice-Yearly-Yeztugo-Leaving-GSK-Behind.jpg https://thepharmadata.com/fda-grants-priority-review-for-winrevair/ 2025-07-03T09:59:24+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/FDA-Grants-Priority-Review-for-WINREVAIR-Label-Update-Based-on-ZENITH-Trial.webp https://thepharmadata.com/fda-grants-accelerated-approval-to-lynozyf/ 2025-07-03T10:17:41+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/FDA-Grants-Accelerated-Approval-to-Lynozyfic™-for-Relapsed-or-Refractory-Multiple-Myeloma.webp https://thepharmadata.com/incyte-announces-inducement-grant-under-nasdaq/ 2025-07-03T10:43:23+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Incyte-Announces-Inducement-Grant-Under-Nasdaq-Rule-5635c4.webp https://thepharmadata.com/who-launches-drive-to-boost-health-taxes/ 2025-07-03T11:39:42+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/WHO-Launches-Drive-to-Boost-Health-Taxes-Save-Lives-2.webp https://thepharmadata.com/asahi-kasei-pharma-launches-global-phase-iii/ 2025-07-03T11:28:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Asahi-Kasei-Pharma-Launches-Global-Phase-III-Trial-of-ART-123-for-CIPN-Prevention.webp https://thepharmadata.com/givastomig-shows-promise-in-1l-gastric-cancer/ 2025-07-03T12:01:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Givastomig-Shows-Promise-in-1L-Gastric-Cancer-I-Mab-at-ESMO-GI-2025.webp https://thepharmadata.com/fda-grants-accelerated-approval-to-lynozyfic/ 2025-07-03T12:21:50+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/FDA-Grants-Accelerated-Approval-to-Lynozyfic-for-Relapsed-Multiple-Myeloma.webp https://thepharmadata.com/oxlumo-now-reimbursed-in-canada/ 2025-07-03T12:52:34+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/OXLUMO®-Now-Reimbursed-in-Canada-for-PH1-Treatment.jpg https://thepharmadata.com/jcr-pharmaceuticals-completes-enrollment/ 2025-07-03T13:58:46+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/JCR-Pharmaceuticals-Completes-Enrollment-in-JR-141-Phase-III-Trial-2.webp https://thepharmadata.com/alume-biosciences-publishes-first-in-human/ 2025-07-03T14:26:37+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Alume-Biosciences-Publishes-First-in-Human-Bevonescein-Nerve-Imaging-Data-in-Nature-Communications.jpg https://thepharmadata.com/briacell-adds-new-phase-3-trial-sites/ 2025-07-03T14:42:19+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/BriaCell-Adds-New-Phase-3-Trial-Sites-Including-Yale-and-LA-Cancer-Network.webp https://thepharmadata.com/abeona-sells-priority-review-voucher/ 2025-07-03T14:53:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Abeona-Sells-Priority-Review-Voucher-for-155-Million.webp https://thepharmadata.com/pneumagen-publishes-positive-phase-ii/ 2025-07-03T15:10:32+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Pneumagen-Publishes-Positive-Phase-II-Data-for-Broad-Spectrum-Antiviral-Neumifil-scaled.webp https://thepharmadata.com/sunshine-biopharma-launches-niopeg/ 2025-07-03T15:22:16+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Sunshine-Biopharma-Launches-NIOPEG®-into-10B-Biologics-Market.webp https://thepharmadata.com/ac102-eliminates-tinnitus-in-preclinical-study/ 2025-07-03T15:50:50+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/AC102-Eliminates-Tinnitus-in-Preclinical-Study.jpg https://thepharmadata.com/novocure-to-present-final-panova-3-data/ 2025-07-03T16:02:53+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Novocure-to-Present-Final-PANOVA-3-Data-in-Pancreatic-Cancer-at-ESMO-GI-2025.jpg https://thepharmadata.com/medimaps-launchmedimaps-launches/ 2025-07-03T16:15:18+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Medimaps-Launches-Next-Gen-TBS-Osteo-Software-in-Europe.webp https://thepharmadata.com/biosynth-opens-new-bioconjugation/ 2025-07-03T16:39:13+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Biosynth-Opens-New-Bioconjugation-Suite-in-Berlin.jpg https://thepharmadata.com/dyadic-international-rebrands-as-dyadic/ 2025-07-03T16:51:44+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Dyadic-International-Rebrands-as-Dyadic-Applied-BioSolutions.webp https://thepharmadata.com/synedgen-names-dr-laura-saward-ceo-dr-kenton/ 2025-07-03T17:10:51+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Synedgen-Names-Dr.-Laura-Saward-CEO-Dr.-Kenton-Gregory-CMO.webp https://thepharmadata.com/2025-gynecology-licensing-trends-report/ 2025-09-30T13:00:07+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/2025-Gynecology-Licensing-Trends-Report-150-Deals-by-Company-Therapy-Tech.webp https://thepharmadata.com/croivalve-secures-horizon-europe-eic-accelerator-funding/ 2025-07-03T17:41:17+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/CroiValve-Secures-Horizon-Europe-EIC-Accelerator-Funding.webp https://thepharmadata.com/who-reports-on-role-in-global-nuclear-emergency-drill/ 2025-07-04T10:19:35+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/WHO-Reports-on-Role-in-Global-Nuclear-Emergency-Drill.webp https://thepharmadata.com/actair-promotional-activities/ 2025-07-04T10:28:45+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Actair®-Promotional-Activities-Transition-in-Japan.jpg https://thepharmadata.com/kennedy-adopts-rsv-guidance-from-acip-panel/ 2025-07-04T10:40:49+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Kennedy-Adopts-RSV-Guidance-From-ACIP-Panel-He-Dismissed.webp https://thepharmadata.com/regeneron-wins-fda-nod-for-myeloma-drug-unlocks-600m-potential/ 2025-07-04T10:54:52+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Regeneron-Wins-FDA-Nod-for-Myeloma-Drug-Unlocks-600M-Potential.webp https://thepharmadata.com/biotech-leaders-investors-urge-fda-to-keep-mifepristone-access/ 2025-07-04T11:06:15+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/Biotech-Leaders-Investors-Urge-FDA-to-Keep-Mifepristone-Access.webp https://thepharmadata.com/innocares-adc-icp-b794-trial-approved-in-china/ 2025-07-04T11:25:25+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/InnoCares-ADC-ICP-B794-Trial-Approved-in-China.webp https://thepharmadata.com/iss-backs-glass-lewis-in-supporting-sinovacs/ 2025-07-04T11:52:21+05:30 https://thepharmadata.com/wp-content/uploads/2025/07/ISS-Backs-Glass-Lewis-in-Supporting-SINOVACs-Current-Board.webp